期刊文献+

Epidemiology of hepatocellular carcinoma in nonalcoholic fatty liver disease

原文传递
导出
摘要 Along with the changes in our food culture and lifestyle,conditions such as obesity,diabetes mellitus,and metabolicsyndrome have been on the rise,and the incidence of nonalcoholic fatty liver disease(NAFLD),which is closelyrelated to these diseases,has also increased rapidly.Despite being a risk factor for the development of hepatocellularcarcinoma(HCC),NAFLD has no established screening method,and HCC originating from NAFLD often tends to be discovered in its advanced and symptomatic stages,which has become an important clinical problem.Even though the carcinogenicity rate among the entire population of NAFLD patients is not high compared to that of patients with viral hepatitis,since HCC also often develops from non-cirrhotic livers,it is difficult to narrow down the cases that need to be under surveillance.Going forward,it will be important to clarify the clinical characteristics and genetic background of NAFLD-related HCC and establish not only a useful surveillance method but also preventive methods.
出处 《Hepatoma Research》 2019年第12期12-25,共14页 肝癌研究(英文版)
  • 相关文献

参考文献5

二级参考文献47

  • 1Xiao-Yan Duan, Liang Qiao and Jian-Gao Fan Department of Gastroenterology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, China ,Storr Liver Unit at the Westmead Millennium Institute, the University of Sydney at Westmead Hospital, Westmead, NSW 2145, Australia.Clinical features of nonalcoholic fatty liver disease-associated hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2012,11(1):18-27. 被引量:16
  • 2[1]Kodali VP,Gordon SC,Silverman AL,McCray DG.Cryptogenic liver disease in the United States:further evidence for non-A,non-B,and non-C hepatitis.Am J Gastroenterol 1994; 89:1836-1839
  • 3[2]Greeve M,Ferrell L,Kim M,Combs C,Roberts J,Ascher N,Wright TL.Cirrhosis of undefined pathogenesis:absence of evidence for unknown viruses or autoimmune processes.Hepatology 1993; 17:593-598
  • 4[3]Ayata G,Gordon FD,Lewis WD,Pomfret E,Pomposelli JJ,Jenkins RL,Khettry U.Cryptogenic cirrhosis:clinicopathologic findings at and after liver transplantation.Hum Pathol 2002; 33:1098-1104
  • 5[4]Uchida T,Shimojima M,Gotoh K,Shikata T,Tanaka E,Kiyosawa K."Silent" hepatitis B virus mutants are responsible for non-A,non-B,non-C,non-D,non-E hepatitis.Microbiol Immunol 1994; 38:281-285
  • 6[5]Del Gaudio A,Boschi L,Del Gaudio GA,Mastrangelo L,Munari D.Liver damage in obese patients.Obes Surg 2002; 12:802-804
  • 7[6]Ratziu V,Giral P,Charlotte F,Bruckert E,Thibault V,Theodorou I,Khalil L,Turpin G,Opolon P,Poynard T.Liver fibrosis in overweight patients.Gastroenterology 2000; 118:1117-1123
  • 8[7]Fassio E,Alvarez E,Dominguez N,Landeira G,Longo C.Natural history of nonalcoholic steatohepatitis:a longitudinal study of repeat liver biopsies.Hepatology 2004; 40:820-826
  • 9[8]Caldwell SH,Oelsner DH,Iezzoni JC,Hespenheide EE,Battle EH,Driscoll CJ.Cryptogenic cirrhosis:clinical characterization and risk factors for underlying disease.Hepatology 1999; 29:664-669
  • 10[9]Poonawala A,Nair SP,Thuluvath PJ.Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis:a casecontrol study.Hepatology 2000; 32:689-692

共引文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部